Intellectus Partners LLC Has $2.47 Million Stock Position in Intuitive Surgical, Inc. $ISRG

Intellectus Partners LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,545 shares of the medical equipment provider’s stock after purchasing an additional 155 shares during the quarter. Intellectus Partners LLC’s holdings in Intuitive Surgical were worth $2,470,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Chilton Capital Management LLC increased its position in Intuitive Surgical by 614.3% in the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 43 shares in the last quarter. TD Capital Management LLC increased its position in Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares in the last quarter. 1248 Management LLC acquired a new stake in Intuitive Surgical in the 1st quarter valued at about $30,000. Princeton Global Asset Management LLC acquired a new stake in Intuitive Surgical in the 2nd quarter valued at about $30,000. Finally, Bank of Jackson Hole Trust increased its position in Intuitive Surgical by 70.5% in the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after acquiring an additional 31 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.8%

Shares of NASDAQ ISRG opened at $534.28 on Monday. The firm has a market capitalization of $191.53 billion, a PE ratio of 70.67, a price-to-earnings-growth ratio of 4.94 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm’s 50-day moving average is $464.32 and its 200-day moving average is $498.73.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm earned $1.84 EPS. The company’s revenue for the quarter was up 22.9% on a year-over-year basis. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Daiwa Capital Markets raised their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd. BTIG Research raised their price objective on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Finally, The Goldman Sachs Group raised their target price on shares of Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $608.92.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 7,562 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 28th. The shares were sold at an average price of $548.43, for a total transaction of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at $193,595.79. This trade represents a 95.54% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Craig H. Barratt sold 2,193 shares of Intuitive Surgical stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 96,011 shares of company stock worth $50,309,042 over the last ninety days. 0.70% of the stock is owned by corporate insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.